Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2013-07-20 / J Gastrointest Surg 2013 Sep;17(9):1609-17Current status of immunotherapy for the treatment of biliary tract cancer
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2013-02-01 / Hum Vaccin Immunother 2013 May;9(5):1069-72Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2012-03-01 / J Hepatobiliary Pancreat Sci 2012 Mar;19(2):171-8[The case of tumor escape mechanism by changing their tumor-associated antigens]
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2009-11-01 / Gan To Kagaku Ryoho 2009 Nov;36(12):1988-90[Dendritic cell vaccine for intrahepatic cholangio cellular carcinoma–a study of relationship between immuno-reaction and clinical outcome]
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2009-11-01 / Gan To Kagaku Ryoho 2009 Nov;36(12):1964-6A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors
/in Dendritic Cells, Gallbladder Cancer, International Publications, Pancreatic Cancer /von 2008-01-01 / Cancer Ther 2008;6(B):955-964Successful immunological treatment of gallbladder cancer in India–case report
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2006-09-01 / J Zhejiang Univ Sci B 2006 Sep;7(9):719-24Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case
/in Gallbladder Cancer, International Publications /von 2006-01-01 / Surg. Today 2006;36(6):559-62Prognostic significance of CD83 positive, mature dendritic cells in the gallbladder carcinoma
/in Gallbladder Cancer, International Publications /von 2005-08-01 / Oncol. Rep. 2005 Aug;14(2):353-6
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de